Clinical trials sponsored by Geneplus-Beijing Co. Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Geneplus-Beijing Co. Ltd.

• Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients
  NCT06098560 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
  NCT05965557 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Timing of ctDNA Testing in Advanced Breast Cancer
  NCT07681323 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ctDNA Monitoring in Early Breast Cancer
  NCT04353557 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Geneplus-Beijing Co. Ltd. recruiting for?

Geneplus-Beijing Co. Ltd. is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.